First Trust Advisors LP Ligand Pharmaceuticals Inc Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, First Trust Advisors LP holds 35,337 shares of LGND stock, worth $4.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,337

Previous 31,835 11.0%

Holding current value

$4.06 Million

Previous $2.68 Million 31.95%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$82.7 - $110.11 $289,615 - $385,605	3,502 Added 11.0%	35,337 $3.54 Million
Q2 2024 Aug 13, 2024	BUY	$68.53 - $87.91 $761,368 - $976,680	11,110 Added 53.61%	31,835 $2.68 Million
Q1 2024 May 13, 2024	SELL	$68.64 - $89.2 $33,770 - $43,886	-492 Reduced 2.32%	20,725 $1.51 Million
Q4 2023 Feb 13, 2024	BUY	$49.57 - $72.63 $161,697 - $236,919	3,262 Added 18.17%	21,217 $1.52 Million
Q3 2023 Nov 13, 2023	BUY	$58.86 - $72.67 $1.06 Million - $1.3 Million	17,955 New	17,955 $1.08 Million
Q1 2023 May 15, 2023	BUY	$65.67 - $77.08 $832,498 - $977,143	12,677 Added 296.33%	16,955 $1.25 Million
Q4 2022 Feb 09, 2023	SELL	$61.72 - $96.74 $414,820 - $650,189	-6,721 Reduced 61.11%	4,278 $285,000
Q3 2022 Nov 14, 2022	SELL	$0.01 - $107.56 $28 - $304,717	-2,833 Reduced 20.48%	10,999 $947,000
Q2 2022 Aug 12, 2022	BUY	$74.52 - $117.06 $438,401 - $688,663	5,883 Added 74.01%	13,832 $1.23 Million
Q1 2022 May 13, 2022	BUY	$94.99 - $151.56 $349,468 - $557,589	3,679 Added 86.16%	7,949 $894,000
Q4 2021 Feb 08, 2022	SELL	$127.69 - $165.85 $1.06 Million - $1.37 Million	-8,279 Reduced 65.97%	4,270 $660,000
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $2 Million - $2.83 Million	-19,577 Reduced 60.94%	12,549 $1.75 Million
Q2 2021 Aug 16, 2021	BUY	$113.03 - $155.64 $3.63 Million - $5 Million	32,126 New	32,126 $4.22 Million
Q1 2021 May 14, 2021	SELL	$99.52 - $215.83 $605,479 - $1.31 Million	-6,084 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$80.55 - $106.05 $1.07 Million - $1.41 Million	-13,302 Reduced 68.62%	6,084 $605,000
Q3 2020 Nov 05, 2020	BUY	$89.56 - $126.72 $1.74 Million - $2.46 Million	19,386 New	19,386 $1.85 Million
Q1 2019 May 09, 2019	SELL	$105.93 - $142.47 $2.17 Million - $2.92 Million	-20,526 Closed	0 $0
Q4 2018 Feb 07, 2019	SELL	$128.36 - $272.13 $1.06 Million - $2.24 Million	-8,230 Reduced 28.62%	20,526 $2.79 Million
Q3 2018 Oct 25, 2018	BUY	$211.18 - $274.49 $1.27 Million - $1.65 Million	5,996 Added 26.34%	28,756 $7.89 Million
Q2 2018 Aug 02, 2018	BUY	$150.77 - $207.98 $1.54 Million - $2.12 Million	10,217 Added 81.46%	22,760 $4.72 Million
Q1 2018 Apr 23, 2018	BUY	$138.63 - $182.62 $4,158 - $5,478	30 Added 0.24%	12,543 $2.07 Million
Q4 2017 Feb 08, 2018	BUY	$128.36 - $147.04 $78,171 - $89,547	609 Added 5.12%	12,513 $1.71 Million
Q3 2017 Oct 24, 2017	BUY	$120.91 - $137.94 $1.44 Million - $1.64 Million	11,904	11,904 $1.62 Million

Others Institutions Holding LGND

# of Institutions

259

Shares Held

18M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.94B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Ligand Pharmaceuticals Inc Transaction History